Statum Systems Inc.

Statum Systems Inc.

Secure Medical Communications

Print
Security Type
Common Stock
Categories
Other
Min Investment
$250
Location
Natick, MA
Offering Date
September 17, 2020
Expected Close Date
December 16, 2020
Target Raise
$10.00K-$1.07M
Deal Notes

Price per Share: $1.00

Valuation
$5,000,000

Company Description

Statum Systems provides a patent-pending solution for a critical issue plaguing healthcare delivery: fragmented and unreliable communication among medical teams. Developed by medical professionals frustrated with the communications tools currently available to them, the StatumHEALTH™ platform empowers all healthcare practitioners to communicate and collaborate using a unified smartphone app to provide more efficient and effective caregiver outcomes.

Key Deal Facts

Created by doctors for a communications solution essential for today's health care environment. Advised by several leading healthcare experts including by Dr. John Halamka, president of the Mayo Clinic platform
Innovating breakthrough medical communications technology with 8 patents pending and more to follow
The worldwide demand for the best possible healthcare grows with urgency as the global market for Clinical Communication and Collaboration Systems is expected to grow to $5 billion by 2027

Use of Proceeds

The Company might incur Irregular Use of Proceeds that may include but are not limited to the following over $10,000: Vendor payments.

Management Team / Advisory Board Bios

Fred Lizza
CEO
Fred Lizza is a serial technology company CEO, having led six prior companies ranging in size from pre-revenue startups to $100 million+ in revenue. His experience includes leading a company to its IPO, acquiring businesses to accelerate growth and launching new technologies.


Ara Nazarian, Ph.D
Co-Founder and Chief Science Officer
Ara Nazarian has a Ph.D in biomedical engineering and is Associate Professor at Harvard Medical School, where he is Director of the Nazarian Lab. A passionate entrepreneur, he has co-founded numerous other businesses including Ortholevo, Verispellis and OstyMeditech
He currently services 20 hours per week in his role with the company.


Stephen Okajima
Chief Technology Officer
Stephen Okajima has degrees in biomedical engineering and computer science. He leads Statum Systems’ product development efforts. Mr. Okajima is also a co-founder of Surgibox.


Arman Serebrakian, MD
Co-Founder
Arman Serebrakian is a resident surgeon in plastic and reconstructive surgery at a leading Boston area medical center. Dr. Serebrakian is a daily user of the hospital communications systems in need of improvement. Dr. Serebrakian competed in the 2014 Sochi Olympics in alpine skiing.


Per Suneby
SVP of Corporate Development
Per Suneby is a Board Observer and Advisor to the Company, and also functions as the Head of Corporate Development for Statum Systems. Mr. Suneby is a noted advisor to early stage technology companies with a record of successful innovation. He has held numerous roles, including CEO. Mr. Suneby has an MBA from Harvard Business School.
He currently services 16 hours per week in his role with the company.

Deal Notes

Price per Share: $1.00

Amount Raised : $236,359
Reveal the Score by Voting
_
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
The value of the company compared to similar companies raising money from investors.
Valuation

Security Description

Common stock is a security that represents ownership in a corporation.

Research Reports

No reports have been submitted

Become a Reporter

0 Comments